Cargando…
Hepatic structural enhancement and insulin resistance amelioration due to AT1 receptor blockade
Over the last decade, the role of renin-angiotensin system (RAS) on the development of obesity and its comorbidities has been extensively addressed. Both circulating and local RAS components are up-regulated in obesity and involved in non-alcoholic fatty liver disease onset. Pharmacological manipula...
Autor principal: | Souza-Mello, Vanessa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241531/ https://www.ncbi.nlm.nih.gov/pubmed/28144388 http://dx.doi.org/10.4254/wjh.v9.i2.74 |
Ejemplares similares
-
Lipid-induced hepatic insulin resistance
por: Galbo, Thomas, et al.
Publicado: (2013) -
Blockade of Endothelin-1 Receptor Type B Ameliorates Glucose Intolerance and Insulin Resistance in a Mouse Model of Obstructive Sleep Apnea
por: Polak, Jan, et al.
Publicado: (2018) -
GLP-1 receptor agonism ameliorates hepatic VLDL overproduction and de novo lipogenesis in insulin resistance
por: Taher, Jennifer, et al.
Publicado: (2014) -
Mineralocorticoid receptor blockade for renoprotection
por: Cha, Dae Ryong
Publicado: (2018) -
Peripheral Cannabinoid-1 Receptor Blockade Ameliorates Cystitis Severity
por: Hinden, Liad, et al.
Publicado: (2023)